Sentry Investment Management LLC Sells 41 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Sentry Investment Management LLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 13.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 255 shares of the biotechnology company’s stock after selling 41 shares during the period. Sentry Investment Management LLC’s holdings in Axon Enterprise were worth $151,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Groupama Asset Managment bought a new stake in Axon Enterprise during the third quarter worth about $200,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Axon Enterprise in the third quarter valued at $120,553,000. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Assenagon Asset Management S.A. lifted its stake in shares of Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after buying an additional 111,405 shares during the last quarter. Finally, Champlain Investment Partners LLC lifted its position in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on AXON shares. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday, February 20th. Needham & Company LLC reissued a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday. Finally, Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 15.3 %

Shares of AXON stock opened at $572.40 on Thursday. The stock has a 50-day moving average of $613.42 and a 200-day moving average of $522.06. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $43.65 billion, a price-to-earnings ratio of 147.91, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 1-year low of $265.32 and a 1-year high of $715.99.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.